NCT00317369View on ClinicalTrials.gov

A Dose-finding Study of OPC-6535 in Patients With Active Crohn's Disease

PHASE2TerminatedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

July 11, 2007

Study Completion Date

August 31, 2007

Conditions
Crohn Disease
Interventions
DRUG

OPC-6535(Tetomilast)

Trial Locations (8)

Unknown

Chubu Region

Chugoku Region

Hokkaido Region

Kanto Region

Kinki Region

Kyushu Region

Shikoku Region

Touhoku Region

Sponsors
All Listed Sponsors
lead

Otsuka Pharmaceutical Co., Ltd.

INDUSTRY